FGFR2 and breast cancer: A meta-analysis of genomic studies recognized 84 loci, probably associated with the risk of BC including lymphocyte-specific protein (LSP1), fibroblast growth factor receptor-2 (FGFR2), mitogen-activated kinase-1 (MAP3K1), and trinucleotide repeat containing 9 (TNRC9/LOC643714) (Ellsworth et al., 2010; Michailidou et al., 2015).